Epithelial membrane antigene (EMA) and nm23 suppressor gene in papillary and follicular thyroid carcinomas (CROSBI ID 537351)
Prilog sa skupa u zborniku | stručni rad
Podaci o odgovornosti
Pešutic-Pisac, Valdi ; Punda, Ante ; čapkun, Vesna ; Tomić, Snježana ; Petric S., Marinkovic M., Staničić, Ante ; Pranić-Kragić, Anka, Juretić-Kuscic, LJ
engleski
Epithelial membrane antigene (EMA) and nm23 suppressor gene in papillary and follicular thyroid carcinomas
Wishing to improve the efficiency of the "Team for thyriod diseases2 that exists in our clinical hospital last ten years, we made a clinicopathologic study of papillary and follicular carcinomas treated in ten years from 1988 to 1998. Although the survival rate was excellent (97%), all patients that passed away had carcinoma associated with unfavorable factors - men, older age, follicular carcinoma, tumor size >2.5 cm, distant metastases, high grade EMA and low grade nm32. according to these results we decieded to performe routinely immunostaining for EMA and nm32 on all papillary and follicular carcinomas.
Epithelial membrane antigene; nm23 suppressor gene; papillary and follicular thyroid carcinomas
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
2001.
objavljeno
Podaci o matičnoj publikaciji
Podaci o skupu
European Association of Nuclear Medicine Annual Congress
predavanje
25.08.2001-29.08.2001
Napulj, Italija